E
NYMX

Ergoteles’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Ergoteles’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-101,332
Closed -$132K – 1741
2021
Q4 		$132K Sell
101,332
-83,601
-45% -$133K 0.01% 1114
2021
Q3 		$381K Sell
184,933
-1,277
-0.7% -$2.26K 0.01% 697
2021
Q2 		$294K Buy
+186,210
New +$345K 0.01% 1077

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.06B AUM 19.66% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $1.65B AUM 31.52% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return